Connect with a Global Community of 60+ MASH Drug Development Experts
The 10th MASH Drug Development Summit offers a unique opportunity to connect directly with 70+ senior discovery, translational, clinical and regulatory leaders actively advancing the next generation of MASH therapeutics. As the field evolves beyond early successes toward differentiated therapies capable of delivering meaningful fibrosis improvement and long-term patient benefit, developers are actively seeking innovative technologies, services and partners that can help overcome key challenges across the drug development lifecycle.
This is your exclusive opportunity to connect with them and position yourself as their next partner of choice.
Showcase your biomarker, diagnostic or AI-enabled pathology solutions
Showcase to developers seeking to improve patient stratification, strengthen endpoint interpretation and reduce reliance on liver biopsy, demonstrating how your technologies can accelerate decision-making and improve clinical trial efficiency
Position your preclinical, translational and discovery platforms as essential tools for improving clinical predictability
Therefore, helping drug developers reduce translational risk, strengthen target validation and identify the most promising therapeutic candidates earlier in development
Demonstrate your clinical development, regulatory or CRO expertise
Demonstrate to organizations navigating evolving standards of care, non-invasive endpoints and increasingly complex trial designs, establishing your company as a trusted partner for efficient MASH development
Connect directly with decision-makers developing next-generation therapies
Including combination approaches, anti-fibrotic mechanisms, precision medicine strategies and advanced fibrosis programs, showcasing how your solutions can accelerate development and improve the likelihood of clinical and commercial success
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as exclusive dinners to help elevate your brand.
Presenting Slots
Data-driven or case study-led presentations to position yourself as a thought-leader.
Leading Innovation
Expert panels to shape forward-thinking discussions.
Full Delegate List
Gain exclusive access to the Full Delegate List to plan your conversations in advance.
Exhibiting
Raise brand awareness and answer questions from prospect customers.
Networking
Engage in 1-2-1 conversations with industry or be part of the organized networking options to generate commercial collaborations.
Bespoke Hosting
Host breakfast, lunches, dinners for drinks receptions to have exclusive time with your target audience.
Champion the Industry
Be part of the RAS community and position yourself as an advocate for innovation and achievements in the RAS-targeted therapeutics space.
Branding
On-site and website branding to highlight your company at the forefront of the RAS field.
Key Services & Solutions
Biomarkers & Diagnostics:
Providers of non-invasive biomarkers, diagnostic assays and endpoint solutions that support patient stratification, disease monitoring and treatment response assessment, helping developers reduce reliance on liver biopsy and improve clinical development efficiency
AI Pathology & Digital Health:
Innovative companies offering AI-enabled pathology platforms, digital assessment tools and advanced analytics capable of improving fibrosis staging, reducing variability in endpoint interpretation and strengthening development decision-making
Preclinical & Translational Models:
Specialized partners providing human-relevant in vitro, in vivo and ex vivo models to improve target validation, strengthen translational confidence and enhance prediction of clinical efficacy across MASH programs
Attending Companies Include